Department of Anatomic Pathology, Pathological Sciences, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka-shi, Fukuoka-ken, 812-8582, Japan.
Department of Pathology, Osaka City General Hospital, 2-13-22 Miyakojima-Hondori, Miyakojima-ku, Osaka-shi, Osaka-fu, 534-0021, Japan.
Virchows Arch. 2019 Oct;475(4):467-477. doi: 10.1007/s00428-019-02622-9. Epub 2019 Aug 7.
Solitary fibrous tumor (SFT) is a soft-tissue neoplasm of intermediate malignant potential, presenting a wide histopathological spectrum. Poorer prognosis of hemangiopericytoma of the central nervous system (CNS), hypoglycemic SFT, and dedifferentiation are well-known characters of SFT, but their clinical significance were not demonstrated enough by large-sized study. Here, the clinicopathological features of SFTs are reviewed and the relationship between genetics and clinicopathological features is examined using 145 SFT cases. All cases were STAT6 IHC-positive and/or NAB2-STAT6 fusion gene-positive. Tumor location was classified into three categories: 30 pleuropulmonary, 96 non-pleuropulmonary/non-central nervous system (CNS), and 18 CNS tumors. The tumor developed recurrence in 21 of 93 available cases (22.5%), metastasis in 11 of 93 (11.8%), and tumor death in 9 of 93 (9.6%). Hypoglycemia occurred in 2 primary tumors and 1 metastatic tumor among 63 reviewable cases, and dedifferentiation occurred in 10 cases (6.8%) including 6 primary tumors, 2 recurrent tumors, and 2 metastatic tumors. Recurrence was positively associated with CNS location (p = 0.0109) and hypoglycemia (p = 0.001); metastasis was positively associated with CNS location (p = 0.0231), hypoglycemia (p < 0.0001), and dedifferentiation (p < 0.0001), while metastasis was negatively correlated with pleural location (p = 0.0471). Tumor death was positively associated with male sex (p = 0.0154), larger size (p = 0.0455), hypoglycemia (p < 0.0001), and dedifferentiation (p < 0.0001). Multivariate analysis revealed independent statistical significance of dedifferentiation for overall survival (p = 0.0467). Exon variant of the fusion gene had no statistical correlation with clinical outcome. In conclusion, dedifferentiation is a major prognostic factor of SFT, and specific location such as cerebromeningeal and intra-abdominal site and hypoglycemia also had a high risk for unfavorable prognosis.
孤立性纤维瘤(SFT)是一种潜在恶性程度中等的软组织肿瘤,具有广泛的组织病理学特征。中枢神经系统(CNS)血管外皮细胞瘤的预后较差、低血糖性 SFT 和去分化是 SFT 的显著特征,但这些特征在大型研究中并未得到充分证明。本研究通过 145 例 SFT 病例,回顾了 SFT 的临床病理特征,并探讨了遗传学与临床病理特征之间的关系。所有病例的 STAT6 IHC 均为阳性,且/或 NAB2-STAT6 融合基因阳性。肿瘤位置分为三类:30 例胸膜肺,96 例非胸膜肺/非中枢神经系统(CNS),18 例中枢神经系统肿瘤。93 例可评估病例中,21 例(22.5%)出现肿瘤复发,11 例(11.8%)出现肿瘤转移,9 例(9.6%)肿瘤死亡。在 63 例可评估病例中,2 例原发性肿瘤和 1 例转移性肿瘤出现低血糖,10 例(6.8%)出现去分化,包括 6 例原发性肿瘤、2 例复发性肿瘤和 2 例转移性肿瘤。复发与中枢神经系统位置(p=0.0109)和低血糖(p=0.001)呈正相关;转移与中枢神经系统位置(p=0.0231)、低血糖(p<0.0001)和去分化(p<0.0001)呈正相关,而与胸膜位置(p=0.0471)呈负相关。肿瘤死亡与男性(p=0.0154)、肿瘤较大(p=0.0455)、低血糖(p<0.0001)和去分化(p<0.0001)呈正相关。多变量分析显示,去分化对总生存期有独立的统计学意义(p=0.0467)。融合基因外显子变异与临床结局无统计学相关性。总之,去分化是 SFT 的一个主要预后因素,而特定部位,如脑脊膜和腹腔内部位,以及低血糖也有不良预后的高风险。